Pralatrexate Injection
Product Images NDC 65219-550

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pralatrexate (NDC 65219-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pra09 0000 01)

Chemical structure diagram of pralatrexate, the active ingredient. The image shows the molecular formula with labeled atoms and bonds, highlighting the arrangement of carbon, hydrogen, nitrogen, oxygen atoms, and functional groups characteristic of pralatrexate.*

FDA Label Image

Fresenius Kabi Logo (Pra09 0000 02)

FDA Label Image

Fresenius Kabi Logo (Pra09 0000 03)

FDA Label Image

Principal Display Panel – Pralatrexate Injection 20 mg/ml – Carton (Pra09 0000 04)

Label for Pralatrexate Injection 20 mg/mL in 1 mL vial, intended for intravenous use. The label includes the NDC 65219-550-01 and states contents and storage instructions. It is labeled for single-dose use and manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, made in Germany.*

FDA Label Image

Principal Display Panel – Pralatrexate Injection 20 mg/ml – Vial Label (Pra09 0000 05)

Label for Pralatrexate Injection 20 mg/mL, 1 mL single-dose vial. The label states 'Do not dilute,' includes the NDC 65219-550-01, and notes the product is prescription only (Rx only). Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois.*

FDA Label Image

Principal Display Panel – Pralatrexate Injection 40 mg/2 mL – Carton (Pra09 0000 06)

Label for Pralatrexate Injection 40 mg/2 mL (20 mg/mL) intravenous solution. The label indicates a 2 mL vial containing 40 mg pralatrexate with sodium chloride and pH adjusters. It is manufactured by Fresenius Kabi USA, LLC, made in Germany. Storage instructions include refrigeration and protection from light. The label includes barcodes and the Fresenius Kabi logo.*

FDA Label Image

Principal Display Panel – Pralatrexate Injection 40 mg/2 mL – Vial Label (Pra09 0000 07)

Label for Pralatrexate Injection 40 mg/2 mL (20 mg/mL) intravenous solution. The label includes the NDC number 65219-552-02, indicates it is Rx only, and specifies the manufacturer as Fresenius Kabi USA, LLC, located in Lake Zurich, IL. The label also contains a barcode and a note stating 'Do not dilute.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.